Greenwich LifeSciences Inc
Greenwich LifeSciences Inc logo
GLSI

Greenwich LifeSciences Inc (GLSI)

$9.551.55%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$9.35
Day's Range
$10.2
$6.82
52-Week Range
$48.5
1 month return5.14%
3 month return0.21%
1 year return75.63%
5 year return92.0%

Company Information

Greenwich LifeSciences is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein. In a randomized, single-blinded, placebo-controlled, multi-center (16 sites led by MD Anderson Cancer Center) Phase IIb clinical trial, no recurrences were observed in the HER2/neu 3+ adjuvant setting after median 5 years of follow-up, if the patient received the 6 primary intradermal injections over the first 6 months (p = 0.0338). Of the 138 patients that have been treated with GP2 to date over 4 clinical trials, GP2 treatment was well tolerated and no serious adverse events were observed related to GP2 immunotherapy. Greenwich LifeSciences is planning to commence a Phase III clinical trial using a similar treatment regime as the Phase IIb clinical trial.
OrganizationGreenwich LifeSciences Inc
Employees2
CEO
IndustryHealth Technology

Analyst Recommendation

based on 7 analysts ratings

Buy
85%
Buy
14%
Hold
0%
Sell

Based on 7 Wall street analysts offering stock ratings for Greenwich LifeSciences Inc(by analysts ranked 0 to 5 stars)

Recommendation Trend

Based on 7 analyst

Current1M Ago3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
169.5M
Book Value
2.04
Dividend Share
0.0
Dividend Yield
0.0
Earnings Share
-0.35
Wall Street Target Price
78.0

Valuation

Trailing PE0.0
Forward PE0.0
Price/Sales (ttm)
0.0
Price/Book (mrq)
7.68
Enterprise Value
178.9M
Enterprise Value/Revenue
0.0
Enterprise Value/Ebitda
0.0

Technicals

50 Day MA
19.19
200 Day MA
30.17

Institutional Holdings

Vanguard Group Inc

2.89%

BlackRock Inc

1.83%

Geode Capital Management, LLC

0.54%

State Street Corporation

0.51%

Ameriprise Financial Inc

0.33%

Northern Trust Corp

0.27%

Discover more

Frequently Asked Questions

What is Greenwich LifeSciences Inc share price today?

Can Indians buy Greenwich LifeSciences Inc shares?

How can I buy Greenwich LifeSciences Inc shares from India?

Can Fractional shares of Greenwich LifeSciences Inc be purchased?

What are the documents required to start investing in Greenwich LifeSciences Inc stocks?

What are today’s High and Low prices of Greenwich LifeSciences Inc?

What are today’s traded volumes of Greenwich LifeSciences Inc?

What is today’s market capitalisation of Greenwich LifeSciences Inc?

What is the 52 Week High and Low Range of Greenwich LifeSciences Inc?

How much percentage Greenwich LifeSciences Inc is down from its 52 Week High?

How much percentage Greenwich LifeSciences Inc is up from its 52 Week low?

What are the historical returns of Greenwich LifeSciences Inc?

Who is the Chief Executive Officer (CEO) of Greenwich LifeSciences Inc?